HUP0002920A2 - Staphylococcus aureus terápia - Google Patents

Staphylococcus aureus terápia

Info

Publication number
HUP0002920A2
HUP0002920A2 HU0002920A HUP0002920A HUP0002920A2 HU P0002920 A2 HUP0002920 A2 HU P0002920A2 HU 0002920 A HU0002920 A HU 0002920A HU P0002920 A HUP0002920 A HU P0002920A HU P0002920 A2 HUP0002920 A2 HU P0002920A2
Authority
HU
Hungary
Prior art keywords
staphylococcus aureus
therapy
strains
methicillin
strain
Prior art date
Application number
HU0002920A
Other languages
English (en)
Inventor
Thalia Ioanna Nicas
David Albert Preston
Michael Lee Zeckel
Original Assignee
Eli Lilly And Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co. filed Critical Eli Lilly And Co.
Publication of HUP0002920A2 publication Critical patent/HUP0002920A2/hu
Publication of HUP0002920A3 publication Critical patent/HUP0002920A3/hu
Publication of HU226593B1 publication Critical patent/HU226593B1/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Atalálmány tárgyát csökkent glikopeptidrezisztenciával rendelkezőStaphylococcus aureus<> törzs által okozott fertőzések kezeléseképezi. Atalálmány szerinti eljárásban methicillinrezisztensStaphylococcus aureus törzseket, azaz például az Mu50törzsethasználják. Ó
HU0002920A 1997-08-22 1998-08-18 Pharmaceutical composition for treatment of disease attributable to strain of staphylococcus aureus HU226593B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5671297P 1997-08-22 1997-08-22
PCT/US1998/017138 WO1999010006A1 (en) 1997-08-22 1998-08-18 Therapy for staphylococcus aureus

Publications (3)

Publication Number Publication Date
HUP0002920A2 true HUP0002920A2 (hu) 2001-01-29
HUP0002920A3 HUP0002920A3 (en) 2001-12-28
HU226593B1 HU226593B1 (en) 2009-04-28

Family

ID=22006150

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002920A HU226593B1 (en) 1997-08-22 1998-08-18 Pharmaceutical composition for treatment of disease attributable to strain of staphylococcus aureus

Country Status (23)

Country Link
US (1) US5994297A (hu)
EP (1) EP0897725B1 (hu)
JP (1) JP2001513573A (hu)
KR (1) KR100589548B1 (hu)
CN (1) CN1276728A (hu)
AT (1) ATE278413T1 (hu)
AU (1) AU747418B2 (hu)
BR (1) BR9811917A (hu)
CA (1) CA2301589A1 (hu)
CZ (1) CZ299098B6 (hu)
DE (1) DE69826795T2 (hu)
DK (1) DK0897725T3 (hu)
EA (1) EA002602B1 (hu)
ES (1) ES2229454T3 (hu)
HU (1) HU226593B1 (hu)
ID (1) ID24908A (hu)
IL (2) IL134597A0 (hu)
NO (1) NO327042B1 (hu)
NZ (1) NZ502762A (hu)
PT (1) PT897725E (hu)
TR (1) TR200000475T2 (hu)
UA (1) UA59410C2 (hu)
WO (1) WO1999010006A1 (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2736860C (en) * 2008-08-30 2020-04-28 Targanta Therapeutics Corp. Methods of treatment using single doses of oritavancin
CN101928331B (zh) * 2009-06-26 2014-05-28 上海来益生物药物研究开发中心有限责任公司 一种化合物及其应用
MX2015011760A (es) 2013-03-15 2016-06-10 Melinta Therapeutics Inc Metodos para tratar infecciones en pacientes obesos y con sobrepeso usando antibioticos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU703106B2 (en) * 1994-01-28 1999-03-18 Eli Lilly And Company Glycopeptide antibiotic derivatives

Also Published As

Publication number Publication date
ATE278413T1 (de) 2004-10-15
EA002602B1 (ru) 2002-06-27
WO1999010006A1 (en) 1999-03-04
EP0897725A2 (en) 1999-02-24
DE69826795T2 (de) 2005-10-06
PT897725E (pt) 2004-12-31
AU8913798A (en) 1999-03-16
EP0897725B1 (en) 2004-10-06
NO20000851L (no) 2000-02-21
NO20000851D0 (no) 2000-02-21
IL134597A (en) 2007-09-20
BR9811917A (pt) 2000-08-15
ES2229454T3 (es) 2005-04-16
ID24908A (id) 2000-08-31
KR20010023108A (ko) 2001-03-26
DE69826795D1 (de) 2004-11-11
CZ299098B6 (cs) 2008-04-23
EA200000250A1 (ru) 2000-08-28
NZ502762A (en) 2001-10-26
HUP0002920A3 (en) 2001-12-28
DK0897725T3 (da) 2004-12-13
KR100589548B1 (ko) 2006-06-15
CA2301589A1 (en) 1999-03-04
AU747418B2 (en) 2002-05-16
US5994297A (en) 1999-11-30
CZ2000619A3 (en) 2001-05-16
HU226593B1 (en) 2009-04-28
NO327042B1 (no) 2009-04-06
JP2001513573A (ja) 2001-09-04
CN1276728A (zh) 2000-12-13
EP0897725A3 (en) 2000-02-09
IL134597A0 (en) 2001-04-30
TR200000475T2 (tr) 2000-08-21
UA59410C2 (uk) 2003-09-15

Similar Documents

Publication Publication Date Title
MY129319A (en) Crystal forms of azithromycin
PT1169370E (pt) Solucoes de poliuretano contendo unidades estruturais de alcoxissilano.
CY1107628T1 (el) Ανθρωπινα ctla-4 αντισωματα και χρησεις αυτων
CY1106234T1 (el) Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus
SE7611103L (sv) Forfarande for framstellning av 2-azetidinonforeningar
WO2003037259A3 (en) Methods for the prevention or treatment of bacterial and fungal infections
ATE355288T1 (de) Verbindungen und therapeutische methoden
CY1105482T1 (el) Χρηση της αζιθρομυκινης στην τοπικη αγωγη οφθαλμικων μολυνσεων
ES2178761T3 (es) Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas.
EA200100700A1 (ru) Гены и белки и их применение
DE60034879T8 (de) Lantibiotikum
DE69828443D1 (de) Säugetierabkömmliche peptide zur behandlung von mikrobiellen infektionen
HUP0002920A2 (hu) Staphylococcus aureus terápia
NO20010140L (no) Kjemotakse-inhiberende protein av Staphylococcus (CHIPS) og dets anvendelse
ATE420852T1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
ES2115975T3 (es) Derivados de triariletileno utilizados terapeuticamente.
HUP0000146A2 (hu) Eljárás Streptococcus pneumoniae-fertőzés kezelésére
ATE312839T1 (de) Anti-infektionsmittel, die gegen gegenüber mehreren arzneimitteln resistente bakterienstämme nützlich sind
ATE212839T1 (de) Hämoregulatorische verbindungen
AU2002224437A1 (en) Monoclonal antibodies to the map protein and method of use in treating or preventing infections
ECSP951463A (es) Compuestos biciclicos

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees